NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The EU patent potentially has some value.

The first issue is that it only has value if a DC vaccine (-L or Direct like version) pus checkpoint combo is approved for gliomas. If that does not happen the patent means nothing.

Second, nobody knows the ownership interest in the patent. It was assigned to UCLA and 3 of LP's companies (NWBO, Cognate and Revimune). For the 3 LP companies she could put the ownership under any shell. Longs will say that it is NWBO, but there is no basis for this. Any or all or possible. Also unclear about the UCLA interest.

The former issue will not be resolved for many years. One would expect LP to PR the patent upon issuance if NWBO does own it.